Intella Interventional Systems Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Intella Interventional Systems Inc.
Interviews with medical device inventors/entrepreneurs Rodney Perkins, MD, and Mir Imran, discussing their successes, such as Collagen and PercuSurge, and the ones that didn't make it.
Japanese distributor Goodman has recently made a couple of US acquisitions. And while the products will primarily feed Goodman's Japanese pipeline, some speculate that this Jappanese powerhouse in interventional cardiology is staking out a US presence.
One of the great mysteries that has long bewildered cardiologists is why as many people with normal cholesterol levels suffer from heart disease and sudden cardiac death as do those with elevated cholesterol. Building on technology developed at the Ernest Orlando Lawrence Berkeley National Laboratory, Berkeley HeartLab has developed a battery of proprietary diagnostic tests that reveal cholesterol abnormalities that go beyond conventional HDL and LDL analysis. Berkeley HeartLab was founded as a cardiovascular reference lab that had a unique diagnostic approach but floundered largely because of the company's inability to convince cardiologists of the benefits of this new method over traditional cholesterol tests. A classic example of a re-start, new management appears to have unearthed the value in the company's proprietary testing program by recognizing the advantage in marketing Berkeley HeartLab's product as a cardiovascular diagnostic planning and disease management tool powered by web-enabled e-health technology.
By focusing on building a better delivery system, Intella hopes to cpature part of the booming stent market.
- Medical Devices